Status:
COMPLETED
Fractional CO2 Laser Assisted Photodynamic Therapy
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Actinic Keratosis
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Nodular Basal Cell Carcinomas: Compare the efficacy and safety of conventional versus fractional laser assisted PDT for difficult to treat nodular cell carcinomas in the face. Actinic keratosis: Co...
Eligibility Criteria
Inclusion
- Age 18 or older
- Skin type I-III
- Fertile women using secure birth control
- Moderate to severe actinic keratoses in the face or on the hands,
- Difficult to treat nodular basal cell carcinomas in the face
Exclusion
- Pregnancy or breast feeding patients
- Patients with porphyria
- Patients with Gorlins syndrome
- Patients with a tendency to produce hypertrophic scars or keloids
- Patients with known allergy to Metvix
- Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic, dementia, mentally ill etc.)
- Patients with pigmented or morphea basal cell carcinomas
- Know herpes simplex virus infection in treatment areas
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT01260987
Start Date
October 1 2010
End Date
August 1 2012
Last Update
July 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Bispebjerg Hospital
Copenhagen, Denmark, DK-2400